Cardinal Health's Model Fair Value Shifts to $249.60 Amid Bullish Analyst Takeaways

Cardinal Health's modeled fair value has been raised from $249.27 to $249.60, driven by analyst commentary on consistent execution and confidence in the core and specialty businesses. Analysts such as Barclays, Leerink, and Citi have raised their price targets, citing strength across the business and potential benefits from acquired assets. However, Citi still flags concerns around Cardinal Health's GMPD businesses. The company is set to report earnings and has completed its existing buyback program.